In vitro Diagnostics
Global changes affecting in vitro diagnostic (IVD) like genomics, personalized medicine and health IT are causing IVD markets to enter an exciting new phase.
Emergence of high value diagnostics is increasing the importance of IVD to healthcare and accelerating the market growth potential, despite the current economy. At Scientia, we help our clients understand new developments and trends in IVD and identify growing and emerging opportunities for strategic action.
Industry Briefings
September 26, 2011
Developing and Commercializing Companion Diagnostics
Aruna Rajan, Michael Jacobson, Kerry Xie and Harry Glorikian
September 01, 2011
Sequencing Trends Worth Watching: Commercial Potential of Technology Demands that Industry and Investors Alike Stay Up to Date
Brian Clancy and Harry Glorikian
July 25, 2011
Concurrent Dx/Rx Review Will Require More Collaboration at FDA and More Outreach by Industry
Related Blog Posts
February 22, 2012
More InVitro Diagnostics Acquisitions Ahead: Non-traditional Companies are Entering the IVD Business
February 6, 2012
"Big Data" will begin improving the bottom line of healthcare players
Industry Reviews
September 15, 2010
The Point-of-Care Diagnostics Market: Growth Drivers and Challenges to Widespread Adoption
June 28, 2010
Strategic Review of Immunoassays: Seeing Beyond the Market Inflection Point
April 17, 2010
Strategic Review of Molecular Diagnostics: Changing Traditional Health Care Paradigm
Scientia in the News
February 10, 2012
Pharmalot interview with Jonathan Pan on Biosimilar Guidance
January 03, 2012
Harry Glorikian interviewed by partneringNEWS in "partnering spotlight"
September 07, 2011
Stock News Now Wire interviews Harry Glorikian on personalized medicine and the impact of sequencing on clinical decisions and therapeutics choices
Press Releases
February 06, 2012
Scientia Advisors Announces Meghan Needham as Director of Marketing
November 16, 2010
Scientia Advisors Appoints Patrick Terry, Principal of New Pricing and Reimbursement/Market Access Practice
October 28, 2010
Scientia Advisors Announces Launch of ScientiaAdvisors Blog
Scientia Leaders »
Harry Glorikian »
Founder and Managing Partner
Arshad Ahmed »
Founding Partner
Patrick Terry »
Principal
Upcoming Conferences
May 29, 2012
Patrick Terry Speaking at Genome-wide Partnering & Dealmaking Conference
CONSULTING CAPABILITIES »
Scientia Advisors consulting capabilities are the result of the skills and expertise of highly talented individuals who have years of experience in the life science and healthcare industries.
SCIENTIA ADVISORS, LLC | info@scientiaadv.com
55 Cambridge Parkway, Suite 300E, Cambridge MA 02142 | Phone: 617-299-3000 | Fax: 617-812-0315
© 2012 Scientia Advisors LLC
